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The blood system is sustained by a pool of hematopoietic stem cells (HSC) that are long-
lived due to their capacity for self-renewal. A consequence of longevity is exposure to stress 
stimuli including reactive oxygen species (ROS), nutrient fluctuation, and DNA damage1,2. 
Damage that occurs within stressed HSC must be tightly controlled to prevent either loss of 
function or the clonal persistence of oncogenic mutations that increase the risk of 
leukemogenesis3,4. Despite the importance of maintaining cell integrity throughout life, how 
the HSC pool achieves this and how individual HSC respond to stress remains poorly 
understood. Many sources of stress cause misfolded protein accumulation in the 
endoplasmic reticulum (ER) and subsequent activation of the unfolded protein response 
(UPR) that enables the cell to either resolve the stress or initiate apoptosis5,6. Here we show 
that human HSC are predisposed to UPR mediated apoptosis compared to closely related 
early progenitors (EP). Following ER stress in HSCs, the PERK branch of the UPR is 
strongly activated, causing ATF4, CHOP and GADD34 upregulation leading to apoptosis. 
In contrast, EP exhibit an adaptive response to stress leading to their survival. Modulation 
of UPR signaling in HSC by overexpression of the co-chaperone ERDJ4 increases HSC 
repopulation capacity in xenograft assays, directly linking the UPR to HSC function. Since 
the UPR is a focal point where different sources of stress converge, our study provides a 
framework for understanding how stress signaling is coordinated within the hematopoietic 
hierarchy and integrated with stemness. Moreover, our results may open up an avenue to 
exploit UPR signaling as a means to improve clinical transplantation of HSC. More 
broadly, these findings reveal how various sources of stress lead to clearance of individual 
HSC to prevent propagation of damaged HSC providing insight into how the stem cell pool 
maintains clonal integrity.  
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The human hematopoietic hierarchy has recently been delineated at the single cell level, 
enabling precise isolation of HSC and progenitor cells (HSPC)7-9 (Supplementary Table 1). We 
performed pathway analysis using the gene expression signature of highly purified HSC from 
lineage depleted cord blood (CB)10, and identified components of the UPR to be enriched in HSC 
compared to progenitor cells (Fig. 1a-b). The UPR encompasses the IRE-1, PERK and ATF6 
pathways6 (Supplementary Fig. 1a). Quantitative PCR showed that several genes of the PERK 
signaling branch were more highly expressed in CD34+CD38– (HSPC) compared to 
CD34+CD38+ (EP) fractions: PERK (1.8-fold), ATF4 (1.5-fold) and its transcriptional targets 
XBP1 (2.3-fold), ERDJ4 (2.1-fold) and CHOP (1.7-fold), and the CHOP targets GADD34 (1.3-
fold) and ERO1LB (2.1-fold, Fig. 1c, Supplementary Fig. 1b-e, Supplementary Table 2). HSPC-
enriched expression of CHOP and ERDJ4 was also seen in adult bone marrow (BM, 
Supplementary Fig. 1f). As well, expression of ATF6 and the ER resident chaperone GRP94 was 
enriched in CB HSPC compared to EP (Fig. 1d-e). However, splicing of XBP1 mRNA, which is 
representative of IRE1 activity, was lower in HSPC compared to EP (2.8-fold, Fig. 1f). Taken 
together, gene expression analysis of HSPC and EP fractions suggests differential activation of 
UPR branches, with increased expression of PERK dependent genes and decreased activity of 
IRE-1 in HSC. 
To examine whether differential basal UPR gene expression reflects distinct ER stress 
responses in HSC and EP, we used two chemical inducers of ER stress, Thapsigargin (Tg) and 
Tunicamycin (Tm). Tg disrupts Ca2+ homeostasis by inhibiting SERCA in the ER membrane, 
depleting Ca2+ from the ER and rapidly activating all three branches of the UPR11. Treatment of 
sorted HSPC and EP with Tg resulted in upregulation of the canonical UPR target genes GRP94, 
GRP78 and ERDJ4 (Fig. 1g, Supplementary Fig. 2a). Interestingly, after 30 minutes, the ratio of 
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spliced over total XBP1 was increased by 9.0±1.1 fold in EP but only 2.4±0.3 fold in HSPC cells 
(Fig. 1g). The level of XBP1 splicing was diminished after 6 hours, consistent with quick 
attenuation of IRE-1 activity12. This indicates that differential XBP1 splicing between HSC and 
EP under steady state conditions is exaggerated upon Tg-induced ER stress, consistent with 
repressed IRE-1 pathway activity in HSC. 
Tm blocks synthesis of N-linked glycoproteins, causing accumulation of unfolded 
proteins in the ER11. Tm treatment resulted in higher upregulation of the canonical UPR genes 
GRP94, GRP78 and ERDJ4 in HSPC compared to EP (Fig. 1h, Supplementary Fig. 2b). The 
level of XBP1 splicing by the IRE1 branch of the UPR was not different between CB-derived 
HSPC and EP following Tm treatment. In contrast, the PERK pathway target CHOP was more 
upregulated in HSPC compared to EP following addition of 0.6 µg/mL Tm (HSPC: 21±1.8-fold, 
EP: 5.9±0.4-fold, Fig. 1h). As well, ATF4 (HSPC: 2.1±0.1-fold, EP: 1.4±0.04-fold) and 
GADD34 (HSPC: 6.2±0.4-fold, EP: 1.8±0.2-fold) were more upregulated in HSPC compared to 
EP (Supplementary Fig. 2b). In adult BM, upregulation of PERK pathway target genes was less 
dramatic, but CHOP expression was higher in HSPC compared to EP following addition of 3 
µg/mL Tm (Supplementary Fig. 2c). Thus, the selective enrichment of PERK pathway target 
genes under basal conditions in HSC is further amplified with Tm treatment. 
Since persistent ER stress and UPR signaling can lead to activation of apoptosis through 
signals downstream of the IRE-1 and PERK branches of the UPR13, we wanted to determine 
whether differential UPR branch activation between HSPC and EP influenced cell fate outcome. 
While Tg treatment did not result in survival differences between HSPC and EP (Supplementary 
Fig. 3a), Tm treatment significantly reduced CB-derived HSPC survival as compared to EP 
(HSPC: 33.3±4.1%, EP: 53.0±4.9% at 0.6 µg/mL Tm; HSPC: 2.1±0.4%, EP: 6.4±0.6% at 3 
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µg/mL Tm, Fig. 2a-b). Adult BM-derived HSPC also showed reduced survival at 3 µg/mL Tm 
(HSPC: 1.1±0.2%, EP: 16.1±4.4%, Fig. 2b). Cell cycle activation of CB-derived HSPC 
decreased but did not eliminate the survival difference with EP, suggesting that Tm sensitivity 
may be partly linked to the inherent quiescence of HSPCs (Supplementary Fig. 3b). Tm reduced 
the clonogenic capacity of CD34+CD38–CD45RA–CD90+ HSC by 19-fold compared to 1.3-fold 
in EP (Fig. 2c, Supplementary Fig. 3c-d). To determine if the selective loss of HSC following 
Tm treatment was due to apoptosis, we cultured CB cells with Tm and assessed apoptosis by 
Annexin-V staining. Although basal levels of viability were similar between HSC and EP, the 
remaining percentage of viable Annexin-V– cells upon Tm treatment was lower for HSC 
compared to EP (HSC: 15±3.5%, EP: 47±6.1% after 40 hours, Fig. 2d-e). Increased apoptosis of 
HSC compared to EP following Tm treatment was confirmed using pre-sorted cells 
(Supplementary Fig. S3e). Overall, these data indicate that Tm-induced ER stress not only elicits 
distinct UPR signaling in HSC compared to EP, but also causes selective apoptosis of HSC. 
ER stress induces eIF2α phosphorylation (eIF2α~P) by PERK, leading to global 
translational attenuation but, paradoxically, ATF4 and CHOP translation is increased14-16. ATF4 
and CHOP can induce apoptosis upon prolonged ER stress, in part by upregulating the eIF2α 
phosphatase GADD34, leading to increased protein load through translational recovery17,18. We 
investigated whether increased apoptosis of HSC compared to EP is linked to preferential 
upregulation of PERK pathway target genes. First, we constructed a lentiviral ATF4 reporter 
vector that marks transduced cells with TagBFP while GFP provides a measure for the ATF4 
translation rate, which is increased when eIF2α~P is high due to the structure of the 5’ end of 
ATF4 mRNA14 (Fig. 3a, Supplementary Fig. 4). As expected, Tm treatment increased the ATF4 
reporter transgene ratio (TGR) in transduced CB cells (2.47±0.17-fold), an effect that was 
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inhibited by the PERK inhibitor GSK2606414 (Fig. 3b). In sorted HSPC and EP, the ATF4 
reporter TGR was higher in HSPC compared to EP (Fig. 3c-d), consistent with increased 
baseline level ATF4 translation in HSPC. Following Tm addition, the TGR was more efficiently 
induced in HSPC compared to EP (HSC: 2.5±0.3 fold, p=0.032; EP: 1.9±0.2 fold, p=0.071, Fig. 
3c-d), indicating that Tm stimulates PERK pathway activity more strongly in HSC compared to 
EP. Second, we over expressed constitutively active GADD34 (ca-GADD34-OE), which 
prevents eIF2α~P and upregulation of ATF4 and CHOP19. Expression of ca-GADD34 
significantly increased HSPC survival following Tm treatment (CTRL: 41.0±5.7%, ca-
GADD34-OE: 61.0±6.6% at 0.6 µg/mL Tm; CTRL: 2.8±0.8%, ca-GADD34-OE: 10.5±1.1% at 3 
µg/mL Tm, Fig. 3e). In EP, the effect did not reach statistical significance (Fig. 3f), indicating 
that ca-GADD34-OE has a more pronounced effect on the stress response of HSC compared to 
EP. As a third method to test PERK pathway involvement, we treated sorted HSPC and EP with 
both Tm and Salubrinal (Sal), which prevents eIF2α dephosphorylation20. Without Sal addition, 
the viability of HSPC was lower than that of EP following Tm treatment (HSPC: 32±3%, EP: 
56±2%, Fig. 3g). Addition of Sal and Tm together preferentially increased HSPC survival, 
resulting in similar viability between HSPC and EP (HSPC: 58±6%, EP: 64±2% at 20 µM Sal), 
indicating that the differential response between HSC and EP to Tm is dependent on GADD34-
mediated dephosphorylation of eIF2α. Fourth, we treated sorted HSPC and EP with both Tm and 
the PERK inhibitor GSK260641421. Like Sal, GSK2606414 reduced the difference in survival of 
Tm treatment between HSPC and EP (HSPC: 54.4±1.9%, EP: 58.7±2.5% at 600 nM 
GSK2606414, Fig. 3h). Thus, HSPC can be protected from Tm-induced apoptosis by interfering 
with the PERK pathway at multiple junctions, and this equalizes the survival between HSPC and 
EP. Collectively, these data demonstrate that Tm-induced ER stress preferentially induces 
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signaling through the PERK branch of the UPR in HSC compared to EP, resulting in selective 
upregulation of pro-apoptotic genes and increased HSC death. 
We next asked whether the UPR was directly involved in regulating HSC function under 
physiological stress conditions. Since CHOP is a main driver of apoptosis upon PERK 
activation13,17, the BM of Chop–/– mice was analyzed. The frequency of mouse stem and 
progenitor cells was not significantly changed in Chop–/– mice compared to wild-type controls, 
but there was a small increase in the basal levels of viability of Lin–Sca-1+c-Kit+ mouse HSC-
enriched cells as well as Lin–Sca-1–c-Kit+ progenitors (Supplementary Fig. 5a-b, Supplementary 
Table 3). This suggests that Chop may be required for the survival/death balance of mouse 
hematopoietic progenitors under physiological conditions. Next, we investigated whether 
modulating UPR signaling would alter human HSC function. The UPR target gene ERDJ4 is a 
co-chaperone that increases the ATPase activity of GRP78 and can be released from the ER 
membrane to associate with the ERAD machinery22,23. These functions may enhance cellular 
protein folding capacity and protect against UPR-induced apoptosis24. ERDJ4 expression was 
highest in purified CB-derived CD49f+ HSC and was reduced in CD49f– multipotent progenitors 
(2.0-fold) as well as all EP fractions (2.2- to 4.1-fold, Fig. 4a). GFP-marked ERDJ4 over 
expression (ERDJ4-OE) lentiviral vectors were constructed to express different transgene levels 
(2.3× with PGK-ERDJ4 and 218× with SFFV-ERDJ4, Fig. 4b-c). In the TEX cell line25, SFFV-
ERDJ4 expression decreased Tm-induced apoptosis (Supplementary Fig. 5c-d). Importantly, CB-
derived HSPC expressing SFFV-ERDJ4 were also protected from Tm-induced cell death (SFFV-
CTRL: 51±4% survival, SFFV-ERDJ4: 62±5% survival, Fig. 4d), suggesting that ERDJ4-OE 
increases the threshold of ER stress needed to induce apoptosis. To test whether ERDJ4 
influences human HSC function, CB cells were transduced with PGK-ERDJ4 and transplanted 
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into immune-deficient mice. After 20 weeks of in vivo competition between GFP+ with GFP– 
cells the percentage of GFP+ cells in the PGK-ERDJ4 group was increased compared to the 
PGK-CTRL group (PGK-CTRL day 0: 28±3.8%, 20 weeks: 27±5.5%; PGK-ERDJ4 day 0: 
44±9.4%, 20 weeks: 70±7.9%; Fig. 4e, Supplementary Fig. 5e). To directly measure the impact 
of ERDJ4-OE on the function and number of HSC, in vivo limiting dilution analysis (LDA) was 
performed. PGK-ERDJ4 transduced CB cells were expanded in vitro and sorted GFP+ cells were 
injected at limiting cell doses, resulting in higher engraftment compared to CTRL cells (Fig. 4f, 
Supplementary Fig. 5f-g). The number of mice with human engraftment was also changed: at the 
low dose, 5 out of 11 control mice were engrafted, compared to 11 out of 12 ERDJ4-OE mice, 
demonstrating by LDA that there was a 4.4-fold increase in the number of repopulating HSC in 
the ERDJ4-OE group (CTRL: 1/73137, ERDJ4-OE: 1/16641, Fig. 4g). These data provide strong 
evidence that a protein folding factor classically associated with the UPR governs HSC function. 
To understand the mechanism by which ERDJ4-OE can improve human HSC function, 
we confirmed that ERDJ4-OE does not change in vivo lineage differentiation, the frequency of 
phenotypic stem and progenitor cell compartments, homing, or progenitor cell engraftment 
(Supplementary Fig. 6a-d). This suggests that ERDJ4-OE does not have a strong effect on 
progenitor cells. As well, secondary LDA showed that ERDJ4-OE does not cause an expansion 
of functional HSC during repopulation (Supplementary Fig. 6e), indicating that the effects of 
ERDJ4-OE are transient. To investigate whether ERDJ4-OE protects against ER stress during 
the in vivo transplantation procedure, CHOP and GADD34 expression was quantified at different 
time points. In PGK-CTRL transduced CB cells, induction of CHOP (2.2±0.6-fold) and 
GADD34 (14.4±4.0-fold) expression was seen 19 hours after transplantation compared to before 
transplantation (Fig. 4h), consistent with a stress response upon transplantation. In contrast, in 
 9 
PGK-ERDJ4 transduced CB cells, this surge in CHOP and GADD34 expression was absent 
(0.82±0.18-fold and 0.98±0.06-fold, respectively). These data suggest that ERDJ4-OE improves 
engraftment by protecting HSC from UPR-induced apoptosis following transplantation. 
Transplantation of human HSC in the xenograft environment places them under replicative 
stress, which causes elevated ROS, DNA damage, and loss of HSC function2. Since both ROS 
and DNA damage can cause ER stress, it is possible that these processes are connected to the 
UPR5. In support of this idea, it was recently shown that ROS accumulation leads to UPR-
mediated apoptosis of HSC26. Our findings implicate ER proteostasis as a critical regulator of 
HSC function during repopulation and suggest that moderation of UPR activation may have 
clinical applications if it improves HSC survival during stem cell transplantation.  
Our results establish a previously unrecognized link between UPR signaling and human 
HSC function. The different branches of the UPR are distinctly activated in HSC compared to 
EP, with the consequence that HSC are rapidly cleared while EP are spared when exposed to 
various sources of stress. This biological response of human HSC is consistent with the HSC 
specific induction of apoptosis seen following DNA damage and ROS accumulation2,27,28. 
Collectively, these data reveal an intrinsic biological focus on preventing propagation of 
damaged HSC that would increase the chance of malignancy. Since terminal differentiation 
effectively purges damaged progenitor cell progeny, clonal purity may be of less importance in 
EP. Loss of HSC and intestinal stem cells in mouse models with deletion of the chaperone Grp78 
support the idea that stem cells of multiple tissues can interrogate ER stress, and utilize 
differential UPR activation to mitigate against potentially pathological damage29,30. Overall, our 
data point to the elimination of individual HSC following stress and damage as a paradigm of 
how the stem cell pool maintains integrity, thereby ensuring long-term tissue maintenance. 
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METHODS SUMMARY 
CB cells were lineage depleted to enrich for CD34+ cells and then sorted by Fluorescence 
Associated Cell Sorting, cultured with ER stress-inducing agents,  and/or transduced with 
lentivirus. Quantitative RT-PCR was performed using a 7900 HT Real-Time PCR system, primer 
sequences are listed in Supplementary Table 2. Apoptosis was assessed by Annexin-V/Sytox or 
cleaved Caspase-3 staining followed by flow cytometry. Intrafemoral transplantation of human 
CB cells into immune-deficient mice was used to read out HSC repopulation activity by flow 
cytometry after 10-20 weeks. Unless otherwise stated, p-values were calculated by two-tailed 
unpaired Student’s t-test. Full Methods are provided in the Supplementary Information. 
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FIGURE LEGENDS 
Figure 1 | Elevated expression of PERK branch genes of the UPR in HSC compared to EP 
and further amplification following Tm-induced stress. a, b, Enrichment of UPR-related 
genes in human HSC compared to progenitors. (a) CD49f+ HSC-enriched genes were analyzed 
for GO category overrepresentation. Node size represents the number of genes corresponding to 
that node. White, yellow and orange node color correspond to FDR<0.15, <0.1 and <0.01, 
respectively. (b) Heatmap showing 40 UPR-related genes, derived from nodes in (a), with 
differential expression between HSC and progenitors by expression array (FDR<0.05). c-f, 
Expression of key UPR genes in sorted HSPC and EP fractions. mRNA levels of (c) PERK 
pathway components, (d) ATF6, (e) GRP78 and GRP94 and (f) IRE1 and spliced XPB1 were 
measured by qPCR. Solid arrows indicate some transcriptional relationships. Expression was 
normalized to the average of GAPDH, ACTB and PBGD. Results are shown as mean±SEM of 
n=6 CB. g, h, UPR branch activation depends on cell type and stressor. CB HSPC and EP 
fractions were sorted and plated in the presence of (g) 0.2 µM Tg or (h) 0.6 µg/mL Tm. mRNA 
was isolated after 0.5, 1, 6, 16 and 40 hours to measure mRNA levels of GRP94, spliced and 
total XBP1, and CHOP by qPCR. DMSO treated controls were the same between (g) and (h). 
Expression was normalized to GAPDH. Data is shown as mean±SEM of n=3 CB, p-value was 
calculated based on treated/control cells and indicates differential response between HSPC and 
EP. HSC: hematopoietic stem cell, MPP: multipotent progenitor, MLP: multilymphoid 
progenitor, CMP: common myeloid progenitor, GMP: granulocyte macrophage progenitor, 
MEP: megakaryocyte erythrocyte progenitor. * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001. 
See also Supplementary Fig. 1-2. 
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Figure 2 | HSC are predisposed to apoptosis compared to EP following treatment with the 
ER stress agent Tm. a, b, Lower survival of CB- and BM-derived HSPC compared to EP in the 
presence of Tm. HSC/HSPC and EP were sorted from CB or adult BM and plated in the presence 
of (a) 0.6 µg/mL or (b) 3 µg/mL Tm. Viable cell counts as a percentage of DMSO controls are 
shown. Symbols represents individual samples of which fractions are connected by a black line, 
the blue line indicates mean±SEM of (a) n=16 CB and n=5 BM or (b) n=7 CB and n=5 BM. c, 
Reduced clonogenic potential of HSC compared to EP upon Tm treatment. 200 HSC or 140 EP 
were sorted into methylcellulose containing DMSO or 0.6 µg/mL Tm and colonies were counted 
13 days later. Data is shown as mean±SEM of n=4 CB. d, e,  Tm treatment causes higher 
apoptosis in HSC compared to EP. CB cells were plated with 0.6 µg/mL Tm. Cells were stained 
for primitive surface markers, Annexin-V and Sytox at different time points. (d) Representative 
flow plots show Annexin-V and Sytox staining. (e) Quantification of Annexin-V– cells is shown 
as mean±SEM of n=5 CB. p-values indicate different viability between HSC and EP. n.s.: not 
significant. * p<0.05, ** p<0.01, **** p<0.0001. See also Supplementary Fig. 3. 
Figure 3 | HSC are predisposed to UPR-induced apoptosis through PERK-eIF2α-ATF4-
CHOP-GADD34 signaling. a, Bidirectional lentiviral reporter vector for ATF4 translation rate. 
All transduced cells are marked by TagBFP; GFP brightness is a measure of ATF4 mRNA 
translation, which is regulated by uORFs and depends on eIF2α~P14. b, ATF4 reporter-
transduced CB cells were treated with 0.6 µg/mL Tm and increasing doses of the PERK inhibitor 
GSK2606414. After 30 hours, the transgene ratio (TGR) between GFP and TagBFP was 
determined. Results are normalized to DMSO and shown as mean±SEM of n=6 CB except at 
600 nM GSK2606414 (n=3). c, d, Higher ATF4 reporter activity in HSPC compared to EP, 
especially following Tm treatment. Sorted HSPC and EP were transduced with the ATF4 
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reporter. After 3 days, 0.6 µg/mL Tm was added to the cells and the TGR was measured 30 
hours later. (c) Representative flow plots show how ATF4 reporter TGR was calculated. (d) 
Results are shown as mean±SEM of n=4 CB. e, f, Over expression of constitutively active 
GADD34 (ca-GADD34 OE) has a more pronounced effect on HSPC compared to EP. (e) HSPC 
and (f) EP were sorted and transduced with CTRL or ca-GADD34-OE lentivirus. After 3 days, 
0.6 µg/mL Tm was added and viable GFP+ cells were counted 40 hours later. Counts as a 
percentage of DMSO controls are shown for n=3 CB. Symbols represent individual CB samples 
of which CTRL or ca-GADD34-OE transduced cells are connected by a black line, p-values 
were calculated using paired t-tests. g, h, Interfering with the PERK pathway at multiple 
junctions preferentially rescues HSC from apoptosis. Sorted HSPC and EP were plated with 0.6 
µg/mL Tm. As well, (g) the GADD34 inhibitor Sal or (h) the PERK inhibitor GSK2606414 was 
added at concentrations indicated on the x-axes. The percentage of Annexin-V–Sytox– cells after 
40 hours is shown as mean±SEM of (g) n=5 CB or (h) n=4 CB. uORF: upstream open reading 
frame, TGR: transgene ratio, MFI: mean fluorescence intensity. * p<0.05, ** p<0.01, *** 
p<0.001, **** p <0.0001. See also Supplementary Fig. 4. 
Figure 4 | ERDJ4 over expression protects from Tm-induced apoptosis and increases HSC 
output and frequency. a, ERDJ4 expression is highest in HSC. mRNA levels were determined 
by qPCR in seven sorted CB populations (Supplementary Table 1). Expression was normalized 
to the mean of GAPDH and ACTB. p-values were calculated in comparison to CD49f+ HSC. 
Results are shown as mean±SEM of n=3 CB. b, c, Lentiviral vectors for overexpression of 
ERDJ4 from the PGK promoter (PGK-ERDJ4) or the stronger SFFV promoter (SFFV-ERDJ4). 
(b) Transduced CB cells were assessed for ERDJ4 expression by qPCR. Expression was 
normalized to GAPDH. Data is shown as mean±SEM of n=2 CB. (c) K562 cells were transduced 
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(>95% GFP+) and cells were lysed for ERDJ4 protein analysis by western blot. ERK2 is shown 
as loading control. d, ERDJ4-OE protects HSPC from Tm-induced apoptosis. Sorted HSPC were 
transduced with SFFV-CTRL or SFFV-ERDJ4. After 3 days, 0.6 µg/mL Tm was added to the 
cells and viable GFP+ cells were counted 40 hours later. Counts as a percentage of DMSO 
controls are shown for n=11 CB. Symbols represent individual samples of which SFFV-CTRL or 
SFFV-ERDJ4 transduced cells are connected by a grey line, p-value was calculated using a 
paired t-test. e, ERDJ4-OE endows CB cells with a competitive advantage. Twenty weeks after 
injection of PGK-CTRL or PGK-ERDJ4 transduced CB cells, mice were sacrificed. The median 
GFP% of the human CD45+ graft in the injected femur was normalized to the initial transduction. 
These normalized values are shown as mean±SEM of n=3 CB with 5 mice per group. f, g, 
ERDJ4-OE increases the number of engrafting HSC. PGK-CTRL or PGK-ERDJ4 transduced CB 
cells were expanded in vitro for 10 days and sorted GFP+ cells were injected at high and low cell 
doses. (f) Total human CD45+GFP+ engraftment in the injected femur after 10 weeks. p-value 
was calculated using the Mann-Whitney test. Pooled data is shown for n=3 CB with 4 mice per 
group, every symbol represents one mouse. (g) HSC frequency was calculated based on the 
number of engrafted mice. h, ERDJ4-OE moderates a surge in CHOP and GADD34 expression 
after transplantation. PGK-CTRL or PGK-ERDJ4 transduced CB cells were expanded in vitro 
for 12 days and transplanted into mice. CD34+GFP+ were sorted and CHOP and GADD34 
expression was analyzed by qPCR at the indicated time points pre- and post-transplant (at 19 
hours and 1 week post-transplant, all GFP+ cells were sorted due to cell number constraints). 
Expression was normalized to GAPDH. Data is shown as mean±SEM of n=3 CB. B/NK: B- and 
NK cell progenitor. * p<0.05, ** p<0.01, **** p<0.0001. See also Supplementary Fig. 5-6. 
Figure 1 
a 
Expression 
b 
IRE1 
CHOP 
PERK 
49
f+
 H
S
C
 
49
f–  
M
P
P 
M
LP
 
C
M
P 
G
M
P 
M
E
P 

	



		
	



	

	




		

	


c 
e f 
d 
g h 
Figure 2 
a b 
d e 
CD34 
C
D
38
 
Sytox 
A
nn
ex
in
-V
 
CD45RA 
C
D
90
 
Sytox 
A
nn
ex
in
-V
 
DMSO (28 hours) 
CD34 
C
D
38
 
Sytox 
A
nn
ex
in
-V
 
CD45RA 
C
D
90
 
Sytox 
A
nn
ex
in
-V
 
Tunicamycin 0.6 µg/mL (28 hours) 
HSC 
EP 
HSC 
EP 
c 
Figure 3 
a 
g 
c 
h 
e f 
ATF4 reporter 
GFP 
Ta
gB
FP
 
DMSO 
Tm 0.6 
HSPC EP 
    ATF4-GFP 
mCMV TagBFP uORF1 uORF2 SFFV 
b 
d 
Transgene Ratio (TGR) = 
    MFI GFP  _ 
MFI TagBFP 
Figure 4 
a b c d e 
C
TR
L 
 PG
K
-E
R
D
J4
 
ERDJ4 
  
ERK2 
f g h 
 1 
SUPPLEMENTARY INFORMATION 
 
Materials and Methods 
Cord blood and bone marrow sample preparation and liquid culture 
Umbilical cord blood, bone marrow or mobilized peripheral blood from healthy individuals were 
obtained with informed consent according to procedures approved by the institutional review 
boards of the University Health Network and Trillium Hospital. Mononuclear cells were ob-
tained by centrifugation on Ficoll, and lineage depletion was performed using the StemSep Hu-
man Progenitor Cell Enrichment Kit according to the manufacturer’s protocol (50–75% CD34+, 
Stemcell Technologies). The lin– cord blood (CB) or lin– bone marrow / mobilized peripheral 
blood cells (BM) cells (50-75% CD34+) were stored in IMDM with 50% FCS and 10% DMSO 
at -150°C until use. For liquid culture, cells were thawed and plated in X-VIVO 10 (BioWhit-
taker) supplemented with 1% BSA, 2 mM L-glutamine, 100 U/ml penicillin-streptomycin, and 
the following cytokines: TPO (7.5 ng/mL), SCF (50 ng/mL), G-CSF (5 ng/mL), Flt3 ligand (50 
ng/mL) and IL-6 (5 ng/mL), referred to as TSGF6 culture. The cell line K562 was expanded in 
IMDM with 10% FCS, 2 mM L-glutamine, 100 U/ml penicillin-streptomycin; TEX cells were 
cultured as reported previously1. Both cell lines tested negative for mycoplasma. 
Fluorescence activated cell sorting and flow cytometry 
Cells were resuspended at 107 cells / mL, stained with surface markers in PBS with 2% FCS, 
washed and sorted on the BD FACS Aria or MoFlo, consistently yielding >95% purity. Flow cy-
tometry was performed using BD LSRII, BD Canto and BD Fortessa cytometers. Data was ana-
lyzed with FlowJo software (Tree Star, Inc.). 
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Annexin-V/Sytox and cleaved Caspase-3 flow cytometry 
For Annexin-V/Sytox apoptosis analysis, cells were stained for surface markers and washed in 
PBS with 2% FCS, resuspended in binding buffer (diluted 10× in H2O, BD cat. number 556454) 
with Annexin-V-APC (50× dilution, BD cat. number 550474) and Sytox Blue (500× dilution, 
Life Technologies cat. number S34857) and stained for 20 minutes at room temperature. Then 
the sample was diluted 5× with binding buffer and cells were analyzed by flow cytometry within 
60 minutes. For cleaved Caspase-3 analysis, cells were permeabilized for 30 min at room tem-
perature with BD Perm 2 buffer (diluted 10× in H2O, cat. number 347692), washed in 2 mL PBS 
with 2% FCS and stained with PE-conjugated cleaved Caspase-3 antibody from BD (cat. number 
561011) for 30 minutes at room temperature. Cells were washed again and resuspended in BD 
Cytofix buffer (diluted 4× in PBS, BD cat. number 554655) before flow cytometry analysis. 
Quantitative RT-PCR 
RNA was extracted from 500–100,000 cells using TRIzol (Life Technologies) and resuspended 
in water for cDNA synthesis using the SuperScript III or SuperScript VILO systems according to 
manufacturer’s instructions (Life Technologies). For each qPCR reaction we added 2× Power 
SYBR Green mix (Life Technologies), 133 nM forward primer and 133 nM reverse primer and 
RNase-free water up to a total volume of 12.5 µL. cDNA was diluted 6–20× with RNase-free 
water and 2.5 µL was added for each reaction. The qPCR was performed using a 7900 HT Real-
Time PCR system with SDS v2.3 software (Applied Biosystems) using standard settings: 50ºC 
for 2 min; 95ºC for 10 min; then 95ºC for 15 sec and 60ºC for 1 min repeated for 40 cycles; then 
dissociation stage. Each assay was run in duplicate for technical variation and for at least 3 CB. 
Arbitrary mRNA concentrations were calculated using the relative standard curve method, and 
mRNA concentrations were normalized to GAPDH, PBGD and/or ACTB, as indicated in the fig-
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ure legends. To determine XBP1 splicing levels, primers were designed that amplify all or only 
spliced XBP1 mRNA, and spliced XBP1 expression was divided by total XBP1 expression (indi-
cated as “spliced / total XBP1”). qPCR primer sequences are listed in Supplementary Table 2. 
Methylcellulose colony forming assays 
Methylcellulose (Stemcell Technologies MethoCult H4034) was supplemented with IL-6 (10 
ng/mL), Flt3 ligand (10 ng/mL) and DMSO or Tunicamycin (0.6 µg/mL). Using the BD FACS 
Aria, 500 CD34+CD38–CD45RA–CD90+ HSC or 350 CD34+CD38+ EP were deposited in 2.5 
mL methylcellulose, and duplicate dishes were plated with 1 mL each (200 HSC or 140 EP per 
dish). After 13 days, colonies were counted and classified based on morphological appearance. 
Lentiviral vectors 
The bidirectional lentiviral MA1 vector2 was modified by replacing ΔNGFR with a loxP-flanked 
Gateway® cassette (Life Technologies) to generate the destination vector pMAL. To generate 
PGK-ERDJ4, pMAL was recombined with the ERDJ4 entry vector from the Mammalian Gene 
Collection through the PlasmID Repository at Harvard3 (Clone ID: HsCD00076069). To gener-
ate ca-GADD34-OE, the GADD34 fragment was amplified by PCR from the pLV-ca-GADD34 
construct4 using the forward primer 5’-CACCATGGCCAGTGTGCTGG-3’ and the reverse pri-
mer 5’-TCACTGGGAAGGGAAGAAGG-3’, cloned into an entry vector using the pENTR Di-
rectional TOPO cloning kit (Life Technologies K2400-20), and this entry vector was recombined 
with pMAL. To generate SFFV-ERDJ4, the PGK promoter of PGK-ERDJ4 was replaced with 
the stronger SFFV promoter5. Control (CTRL) vectors expressed a humanized Renilla Luciferase 
gene or a Stuffer sequence derived from pLKO.1_1.9Kb_stuffer instead of ERDJ4 and ca-
GADD34. The ATF4 reporter lentivirus was made as follows: first, the PGK promoter in pMAL 
was replaced with the stronger SFFV promoter5 and GFP was replaced with TagBFP (Evrogen6) 
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to generate the destination vector pSMALB. Next, the reporter fragment was amplified from 
ATF4.5: 5’ATF4.GFP (Addgene 21852), ATF4.12: 5’ATF4.uORF1AUA.GFP (Addgene 21859) 
and ATF4.14: 5’ATF4.uORF1&2AUA.GFP (Addgene 21861) using the forward primer 5’-
CACCAGCTTTTCTGCTTGCTGTC-3’ and the reverse primer 5’-TTACTTGTACAGCTCGTC 
CATGC-3’. Finally, using the pENTR Directional TOPO cloning kit, fragments were cloned into 
entry vectors, which were then recombined with pSMALB to generate the bidirectional lentiviral 
reporter vectors pSMALB-ATF4.5rep (hereafter referred to as the ATF4 reporter), pSMALB-
ATF4.12rep and pSMALB-ATF4.14rep, respectively. In the ATF4 reporter, mRNA expression 
highly correlates between TagBFP and GFP due to the bidirectional promoter2. To account for 
differences in basal translation between experimental conditions (such as HSPC vs. EP, high vs. 
low transduction, DMSO vs. Tm treatment), we calculated the transgene ratio between GFP and 
TagBFP as a measure of reporter activity: 
TGR = GFP mean fluorescence intensity / TagBFP mean fluorescence intensity. 
Lentivirus production and primary cell transduction 
Viral particles were pseudotyped with the vesicular stomatitis virus G protein using the pMD.G 
vector and third-generation pMDLg/pRRE and pRSVRev vectors were used for packaging in 
293T cells using calcium-phosphate transfection (Clontech cat. number 631312). Lentivirus was 
concentrated 100× by ultracentrifugation, resuspended in X-VIVO 10 (BioWhittaker) supple-
mented with 1% BSA and stored at –80ºC until use. CB cells were thawed and plated in liquid 
TSGF6 culture with double the concentration of all cytokines, and lentiviral suspension was add-
ed at a multiplicity of infection of 5-20 in a total volume of 100 µL (96 well plate) or 400 µL (24 
well plate). After 16 hours, TSGF6 culture medium was added to expand the cells. Transduction 
efficiency was measured using flow cytometry for GFP or TagBFP expression after 72-96 hours. 
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Mouse xenotransplantation, human lin– cell isolation and secondary transplantation 
Mouse xenografts were performed as described previously7 according to protocols approved by 
the University Health Network Animal Care Committee. Briefly, 8-12 week old male NOD/Lt-
scid/IL2Rɣnull (NSG) mice were sub lethally irradiated (225 cGy) 1 day prior to injection. Cells 
were injected intrafemoral with 30 µL PBS. Peripheral blood (80 µL) was taken from the saphe-
nous vein and analyzed by flow cytometry. Mice with >40% human T cells in the peripheral 
blood are likely to harbor an auto-immune clonal T-cell expansion and were excluded from anal-
ysis. To reach statistical significance, all animal studies were repeated with 3 CB with at least 2, 
but generally 5 mice per condition. Animals were not randomized prior to injection, no blinding 
was done for animal studies. After sacrificing the mice, femurs were flushed with 2 mL PBS 2% 
FCS; 50 µL was stained for surface markers and analyzed by flow cytometry. For lineage deple-
tion, BM cells from the femurs and tibias of 5 mice were combined and processed with the 
StemSep Mouse/Human Chimera Enrichment Kit (Stem Cell Technologies) according to the 
manufacturer’s instructions. However, during the antibiotin incubation step, an additional 50 
µL/mL human hematopoietic progenitor enrichment antibody cocktail from the StemSep Human 
Progenitor Cell Enrichment Kit was added to deplete human lineage-positive cells. Limiting di-
lution analysis (LDA) in secondary recipient mice was performed by sorting GFP+ cells from 
pooled BM of primary mice 10 weeks after transplantation. Secondary mice were injected with 
30,000 to 1,000,000 cells and analyzed 10 weeks after transplantation; a secondary mouse was 
scored as positive if it had >0.01% human engraftment. HSC frequency was estimated using the 
ELDA software8 (Extreme Limiting Dilution Analysis, http://bioinf.wehi.edu.au/software/elda/). 
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Analysis of Chop–/– mouse bone marrow 
Femurs, tibias and pelvises of 13 week old male Chop–/– and wild-type littermates were flushed 
to isolate BM cells. Five to ten million cells were stained with antibodies against surface markers 
(HSC panel: lineage markers, c-Kit, Sca-1, CD34 and Flk2. Progenitor panel: lineage markers, c-
Kit, Sca-1, CD34, IL7R and FcγII/IIIR, Supplementary Table 3). Next, cells were stained using 
Annexin-V Pacific Blue conjugate (Biolegend) and 7-AAD according to manufacturer’s instruc-
tions, and analyzed on a BD Fortessa cytometer. 
Tunicamycin, Thapsigargin, Salubrinal, GSK2606414 
Compounds were purchased as follows: Tunicamycin (Tm), Sigma-Aldrich, cat. number T7765; 
Thapsigargin (Tg), Sigma-Aldrich, cat. number T9033; Salubrinal (Sal), Santa Cruz, cat. number 
SZ202332; GSK2606414, Merck Millipore, cat. number 516535. Powder was resuspended in 
DMSO and stored at -20° C until use. Final DMSO concentration was always <0.6% and equal 
between treatment and control groups. Viability analysis was performed after 40 hours of treat-
ment, unless otherwise stated in the figure legend. Viable cells were counted manually by Trypan 
blue exclusion or automated using the BD Canto flow cytometer high throughput sampler (HTS), 
by counting the number of Annexin– and/or Sytox– cells in a specified volume. 
Western blot 
Transduced K562 cells were lysed, separated with SDS-PAGE and transferred onto a polyvinyli-
dene fluoride membrane as previously reported9. Specific antibody to ERDJ4 (Abnova cat. num-
ber H00004189-M09) was detected using secondary HRP-conjugated antibodies (Amersham) 
and visualized by chemiluminescence (Pierce). 
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Gene expression and pathway analysis 
Gene expression data sets were reported previsously10. The genes upregulated in HSC compared 
to progenitor (MLP/CMP/GMP/MEP) with adjusted p-value <0.01 were used for gene ontology 
(GO) analyses with BiNGO11. The algorithm was used with hypergeometric test, multiple test 
correction (Benjamini-Hochberg False Discovery Rate - FDR) and using the whole Homo Sapi-
ens annotation as a reference set. Data was visualized with Cytoscape12; gene sets linked to the 
UPR response were unlinked from the rest of the network for presentation. For the heatmap, we 
checked the expression of all genes belonging to GO categories relative to the UPR response (79 
genes belonging to GO_0006986, GO_0034620, GO_0034976, GO_0030968 categories). Forty 
of these were differentially expressed between HSC and progenitors (FDR <0.05). Their expres-
sion levels in HSC, MPP, MLP, CMP, GMP and MEP were mean centered. 
Statistical analysis 
Unless otherwise stated, mean±SEM values are given and p-values were calculated by two-tailed 
unpaired Student’s t-test. Mann-Whitney tests were performed to compare engraftment levels, 
since these data do not show a normal distribution. ELDA software was used for statistical anal-
ysis of in vivo LDA8 (http://bioinf.wehi.edu.au/software/elda). * p < 0.05, ** p < 0.01, *** p < 
0.001, **** p < 0.0001. 
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Supplementary Fig. 1 | Expression analysis of UPR-related genes. a, Simplified scheme illus-
trating UPR signaling events. Three branches of the UPR are activated upon ER stress: IRE-1, 
PERK and ATF6. IRE-1 splices cytosolic XBP1 mRNA to enable translation of the XBP1s tran-
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scription factor, which upregulates chaperones and ER-associated degradation (ERAD) machin-
ery to resolve ER stress13. PERK initiates a different branch of the UPR through phosphorylation 
of eIF2α, which attenuates global protein synthesis, thus permitting time to restore ER homeosta-
sis14. Prolonged ER stress leads to PERK signaling-mediated upregulation of the proapoptotic 
transcription factor CHOP and its target GADD34. GADD34 dephosphorylates eIF2α leading to 
restoration of global protein translation. However, if ER stress is not resolved, GADD34 upregu-
lation can lead to further accumulation of misfolded proteins, oxidative stress and apoptosis15. 
Yellow highlighted arrows indicate transcriptional regulation. b, Amplification curves of qPCR 
reactions for UPR-related genes. Fluorescence signal during 40 cycles of qPCR reactions on CB-
derived cDNA is shown for a representative experiment. Green line indicates threshold that was 
used to calculate mRNA quantity. c, Dissociation curves were generated to check for the pres-
ence of aspecific amplicons or primer dimers, which would be visible as additional peaks. Each 
line represents the dissociation curve of one qPCR reaction, colors indicate different genes. d, 
Slopes and R2 values of standard curves are shown for a representative experiment. These values 
were calculated separately for each experiment, based on a cDNA dilution series. b–d were per-
formed using SDS v2.3 software. e, Agarose gel analysis of qPCR amplicons. qPCR reactions 
were run on a 3% agarose gel to check for reaction specificity: non-specific amplicons would be 
visible as additional bands. The expected product size is shown above the gel, the ladder sizes 
are indicated on the right. f, BM cells were sorted into CD34+CD38– HSPC and CD34+CD38+ 
EP fractions. mRNA levels for CHOP and ERDJ4 were measured by qPCR. Expression was 
normalized to GAPDH. Results are shown as mean±SEM of n=5 BM samples. ERAD: ER-
associated degradation. **** p < 0.0001.  
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Supplementary Fig. 2 | 
Differential response of 
HSPC and EP to ER 
stress-inducing agents.  
a, b, CB HSPC and EP 
fractions were sorted and 
plated in the presence of 
(a) 0.2 µM Tg or (b) 0.6 
µg/mL Tm. mRNA was 
isolated after 0.5, 1, 6, 16 
and 40 hours and expres-
sion levels of GRP78, 
ERDJ4, GADD34 and 
ATF4 were assessed by 
qPCR. The DMSO treated 
controls were the same between (a) and (b). Expression was normalized to GAPDH. Data is 
shown as mean±SEM of n=3 CB, p-value was calculated based on fold change of treated over 
DMSO control cells and indicates differential response between HSPC and EP. c, BM HSPC and 
EP were sorted and plated in the presence of 0.6 and 3 µg/mL Tm and DMSO control. After 16 
hours, mRNA was isolated and expression levels of CHOP, ERDJ4 and GRP94 was assessed by 
qPCR. Expression was normalized to GAPDH. Data is shown as mean±SEM of n=5 BM.   
Figure S2 
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Supplementary Fig. 3 | Survival of HSC is lower than of EP upon Tm, but not Tg treat-
ment. a, Tg has similar toxicity for sorted HSC and EP fractions. Sorted CB HSC and EP frac-
tions were plated in TSGF6 culture conditions in the presence of 0.2 or 1 µM Tg. Viable cell 
counts as a percentage of DMSO controls are shown as mean±SEM of n=7 CB. b, HSC have 
lower survival than EP following Tm treatment, even after cell cycle induction. Sorted CB HSC 
and EP fractions were plated in TSGF6 culture conditions with double cytokine concentrations 
for 72–96 hours to induce G0 exit of the HSC fraction7. Then, cells were plated in the presence of 
0.6 or 3 µg/mL Tm. Viable cell counts as a percentage of DMSO controls are shown. Symbols 
represents individual samples of which fractions are connected by a black line, the blue line indi-
cates mean±SEM of n=5 CB at 0.6 µg/mL and n=3 CB at 3 µg/mL Tm. c, d, Reduced clonogen-
ic survival of sorted CB HSC compared to EP upon Tm treatment. Total colony number is shown 
in Fig. 2c. Here, data is separated into colony types based on morphological appearance. Data is 
shown as mean±SEM of n=4 CB. e, Increased apoptosis of sorted HSC compared to EP upon Tm 
treatment. Sorted CB HSC and EP fractions were plated in the presence of 0.6 or 3 µg/mL Tm. 
Viable cell counts as a percentage of DMSO controls are shown as mean±SEM of n=4 experi-
ments. ** p<0.01, *** p<0.001, **** p<0.0001. G: granulocyte, M: macrophage, GM: granulo-
cyte/macrophage, BFU: erythroid burst forming unit, mix: multilineage.   
Figure S3 
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Supplementary Fig. 4 | ATF4 reporter 
enables visualization of increased ATF4 
translation upon Tm treatment. a, 
ATF4 reporter validation. Two upstream 
ORFs (uORFs) that are 5’ of the ATF4 
coding sequence in the ATF4 mRNA en-
sure more efficient translation of ATF4 
when eIF2α phosphorylation levels are 
high16,17. A bidirectional lentiviral vector 
was constructed that gives constitutive 
expression of TagBFP to mark transduced 
cells. In the other direction, the SFFV 
promoter drives expression of the 5’ end 
of the ATF4 mRNA which fuses with a 
GFP reporter gene 3’ of the termination codon of uORF2. HeLa cells were transduced with 
pSMALB-ATF4.5rep (hereafter referred to as the ATF4 reporter, >95% transduction efficiency) 
and treated with Tm at 3 µg/mL. Thirty hours later, GFP fluorescence was read out by flow cy-
tometry. b, c, Reporter fluorescence depends on uORFs that regulate ATF4 expression. HeLa 
cells were transduced and treated with Tm at 3 µg/mL. As expected, ATF4-GFP translation is (b) 
repressed in the negative control that has a mutated uORF1 start codon and (c) constitutively 
high in the positive control with mutated start codons for both uORFs16. Histogram plots show 
n=2 technical duplicates (two black lines for DMSO control, two red lines for Tm treatment). 
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Supplementary Fig. 5 | Modula-
tion of UPR genes affects hema-
topoietic stem and progenitor 
cells in vivo. a, Analysis of hema-
topoietic stem and progenitor cell 
frequencies in Chop–/– mice. Flow 
cytometry was performed on mouse 
BM. Each bar graph shows the ab-
solute cell production in each popu-
lation from wild type or Chop–/– 
mice. Cell numbers are expressed as 
cells per 100,000 viable BM cells, 
see Supplementary Table 3 for sur-
face marker overview. Data is 
shown as mean±SD of n=5 mice per 
group. b, Viability analysis of stem 
and progenitor cell populations in 
Chop–/– mice. The percentage of 
viable Annexin-V–7-AAD– cells 
within the HSC-enriched Lin–Sca-
1+c-Kit+ (LSK) and Lin–Sca-1–c-Kit+ progenitor fractions was assessed by flow cytometry. Data 
is shown as mean±SD of technical duplicates of n=5 mice per group. c, Increased Tm survival or 
SFFV-ERDJ4 transduced cells. The hematopoietic TEX cell line1 was transduced with SFFV-
Supplementary Figure 5 
a 
d c 
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CTRL or SFFV-ERDJ4 and plated in the presence of 0.6 µg/mL Tm. After 48 hours, the number 
of transduced cells compared to DMSO treated controls was determined by automated counting 
of GFP+ cells. Data is shown as mean±SD of n=3 independent experiments. d, Tm-induced 
apoptosis is reduced by SFFV-ERDJ4 transduction. Cells from (c) were analyzed for Annexin-V 
and cleaved Caspase-3 expression by flow cytometry. Data is shown as mean±SD of n=3 inde-
pendent experiments. e, PGK-ERDJ4 endows CB cells with a competitive advantage over un-
transduced cells. Three CB pools (Exp. 1-3) were transduced with PGK-CTRL or PGK-ERDJ4 
lentiviruses and injected into 5 mice each. Dashed line indicates GFP% after transduction (day 
0), solid line indicates median GFP% of the human CD45+ graft in the injected femur of xeno-
grafted mice (20 weeks). Every symbol represents one mouse. f, Similar expansion of PGK-
CTRL and PGK-ERDJ4 transduced CB cells in vitro. CB cells were transduced with PGK-CTRL 
or PGK-ERDJ4 lentivirus and expanded for 10 days in liquid culture. Total population doublings 
of transduced GFP+ cells is shown for n=3 CB. g, PGK-ERDJ4 increases HSC output. Three CB 
pools were transduced with PGK-CTRL or PGK-ERDJ4 lentivirus and after 10 days in liquid 
culture, sorted GFP+ cells were injected at high and low cell doses, indicated below the x-axis. 
Total human CD45+GFP+ engraftment in the injected femur after 10 weeks is shown. p-values 
were calculated using the Mann-Whitney test. Every symbol represents one mouse, line shows 
median. Three independent experiments are shown from left to right. LSK: Lin–Sca-1+c-Kit+, 
LT-HSC: long-term HSC, ST-HSC, short-term HSC, MPP, multipotent progenitor, CMP, com-
mon myeloid progenitor, GMP: granulocyte macrophage progenitor, MEP: megakaryocyte 
erythrocyte progenitor. * p < 0.05, ** p < 0.01, *** p < 0.001. 
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Supplementary Fig. 6 | Lineage dif-
ferentiation, progenitor cell fre-
quencies, homing, EP engraftment, 
and serial transplantability are 
maintained upon ERDJ4 over ex-
pression. a, PGK-ERDJ4 transduced 
CB maintains multilineage differen-
tiation potential in vivo. Left: gating 
scheme to assess differentiation of 
the human graft in mouse BM. Rep-
resentative flow plots show quantifi-
cation of CD45+CD19+ B-cells, 
CD45+CD33+ monocytes and granu-
locytes, and CD45−GlyA+ erythroid 
cells within the GFP+ graft. Right: the lineage differentiation 
of CB cells transduced with PGK-CTRL or PGK-ERDJ4 len-
tiviruses into B cells, myeloid cells, T-cells and erythroid 
cells was assessed in the peripheral blood (PB) at 10 and 20 
weeks and in the injected (RF) and non-injected (LF) femur 
at 20 weeks after transplantation. Results are shown as mean±SEM of n=15 mice representing 
n=3 CB. b, ERDJ4 over expression (ERDJ4-OE) does not cause aberrant expansion of stem or 
progenitor cell fractions. To assess the distribution of human stem and progenitor cells, lineage+ 
and mouse cells were depleted from xenografted mouse BM. The remaining human lineage– cells 
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were analyzed by flow cytometry. Left: gating scheme to assess differentiation into HSC, MPP, 
MLP, CMP/MEP and B/NK/GMP fractions. Right: the frequency of human stem and progenitor 
cells within the human CD45+GFP+ graft was assessed 20 weeks after transplantation of PGK-
CTRL or PGK-ERDJ4 transduced CB cells. Results are shown as mean±SEM of n=3 CB. c, 
Homing capacity to the non-injected BM is not altered by ERDJ4-OE. PGK-CTRL or PGK-
ERDJ4 transduced CB cells were expanded for 12 days in TSGF6 liquid culture conditions and 
1E6–1.6E6 cells were transplanted per mouse. After 19 hours, mice were sacrificed to assess 
human CD45+GFP+ engraftment in the non-injected femur. Results were normalized to transduc-
tion efficiency. Every symbol represents one mouse, results of n=3 CB are shown with 2 mice 
per group each. d, Progenitor cells retain normal engraftment capacity with ERDJ4-OE. Sorted 
EP were transduced with PGK-CTRL or PGK-ERDJ4 lentivirus and 8,700-14,000 cells were in-
jected per mouse. After 2 and 4 weeks, mice were sacrificed and the level of human CD45+GFP+ 
engraftment in the injected femur was measured by flow cytometry. Results were normalized to 
transduction efficiency. Every symbol represents one mouse, results of n=3 CB are shown with 3 
mice per group each. e, Frequency of functional human HSC in vivo is maintained with ERDJ4-
OE. CB cells were transduced with PGK-CTRL or PGK-ERDJ4 lentivirus and injected into pri-
mary mice. After 10 weeks, mice were sacrificed and transduced GFP+ cells were sorted from 
their BM. Thirty thousand to one million cells were retransplanted into secondary mice for serial 
LDA. After 10 weeks, the BM of secondary mice was assessed for human engraftment; mice 
were scored as positive if the engraftment level was >0.01%. MLP: multilymphoid progenitor, 
B/NK: B/NK cell progenitor.  
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Supplementary Table 1 | Surface marker phenotypes to separate human stem and progeni-
tor cells subsets 
Population Surface phenotype HSPC CD34+CD38− 
HSC CD34+CD38−CD45RA−CD90+ 
CD49f+ HSC CD34+CD38−CD45RA−CD90+CD49f+ 
MPP CD34+CD38−CD45RA−CD90− 
CD49f− MPP CD34+CD38−CD45RA−CD90−CD49f− 
MLP CD34+CD38−CD45RA+CD90–/lo 
EP CD34+CD38+ 
CMP/MEP CD34+CD38+CD45RA− 
B/NK/GMP CD34+CD38+CD45RA+ 
CMP  CD34+CD38+CD45RA−CD10−CD7−CD135+  
MEP  CD34+CD38+CD45RA−CD10−CD7−CD135−  
B/NK  CD34+CD38+CD45RA+CD10+  
GMP CD34+CD38+CD45RA+CD10−CD7−CD135+  
 
HSC: hematopoietic stem cell, MPP: multipotent progenitor, MLP: multilymphoid progenitor, 
EP: early progenitor, CMP: common myeloid progenitor, MEP: megakaryocyte erythrocyte pro-
genitor, B/NK: B and NK cell progenitor, GMP: granulocyte macrophage progenitor. "HSPC " to 
"HSC" to "CD49f+ HSC" indicates increasing purity of the population: approximately 1:75, 1:20 
and 1:10, respectively18,19. 
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Supplementary Table 2 | Primer sequences used for quantitative RT-PCR 
Gene Primer Sequence 5' to 3' 
ACTB forward CCTGTACGCCAACACAGTGC 
ACTB reverse ATACTCCTGCTTGCTGATCC 
ATF4 forward GCTAAGGCGGGCTCCTCCGA 
ATF4 reverse ACCCAACAGGGCATCCAAGTCG 
ATF6 forward ATGAAGTTGTGTCAGAGAACC 
ATF6 reverse CTCTTTAGCAGAAAATCCTAG 
CHOP/DDIT3 forward GGAGCATCAGTCCCCCACTT 
CHOP/DDIT3 reverse TGTGGGATTGAGGGTCACATC 
ERDJ4 forward TCGGCATCAGAGCGCCAAATCA 
ERDJ4 reverse ACCACTAGTAAAAGCAC-
TGTGTCCAAG ERO1LB forward TCTGGATGATTGCTTGTGTGAT 
ERO1LB reverse GGTCGCTTCAGATTAACCTTGT 
GADD34/PPP1R15A forward CCCAGAAACCCCTACTCATGATC 
GADD34/PPP1R15A reverse GCCCAGACAGCCAGGAAAT 
GRP78/HSPA5/BiP forward TGACATTGAAGACTTCAAAGCT 
GRP78/HSPA5/BiP reverse CTGCTGTATCCTCTTCACCAGT 
GRP94/TRA1 Qiagen assay Qiagen cat. number QT00046963 
 IRE1/ERN1 forward TGCTTAAGGACATGGCTACCATCA  
IRE1/ERN1 reverse CTGGAACTGCTGGTGCTGGA  
PERK/EIF2AK3 forward AATGCCTGGGACGTGGTGGC 
PERK/EIF2AK3 reverse TGGTGGTGCTTCGAGCCAGG 
PBGD forward CATGTCTGGTAACGGCAATG 
PBGD reverse GTACGAGGCTTTCAATGTTG 
XBP1 spliced forward CGCTTGGGGATGGATGCCCTG 
XBP1 spliced reverse CCTGCACCTGCTGCGGACT 
XBP1 total forward GGCATCCTGGCTTGCCTCCA 
XBP1 total reverse GCCCCCTCAGCAGGTGTTCC 
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Supplementary Table 3 | Surface marker phenotypes to separate mouse stem and progeni-
tor cell subsets 
Population 
Surface phenotype LSK Lin–Sca-1+c-Kit+ 
LT-HSC Lin–Sca-1+c-Kit+Flk2–CD34– 
ST-HSC Lin–Sca-1+c-Kit+Flk2–CD34+ 
MPP Lin–Sca-1+c-Kit+Flk2+CD34+ 
Progenitor Lin–Sca-1–c-Kit+ 
CMP Lin–Sca-1–c-Kit+FcγII/IIIR–CD34+ 
GMP Lin–Sca-1–c-Kit+FcγII/IIIR+CD34+ 
MEP Lin–Sca-1–c-Kit+FcγII/IIIR–CD34–  
 
LT-HSC: long-term hematopoietic stem cell. ST-HSC: short term hematopoietic stem cell. MPP: 
multipotent progenitor. CMP: common myeloid progenitor. GMP: granulocyte macrophage pro-
genitor. MEP: megakaryocyte erythrocyte progenitor. 
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